Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > No financing
View:
Post by Turtle4 on Dec 12, 2024 3:41am

No financing

The last update (two and a half months ago) stated that funding was needed and that information would be published shortly. So it sounded like it was already in the bag. But now that nothing has been heard for so long, we have to assume that the deal has fallen through. Now we not only have to worry about the anti-aging launch next month, but also about the continued existence of the entire company.
Comment by tylerreddick on Dec 12, 2024 8:46am
Well, to be honest, penny stocks feed bs to their shareholders all the time. But you have to remember that their jobs are on the line if the company fails, so I expect them to get some kind of deal done, although it will probably mean we have to give up something in return, maybe as much as half the company. I would be ok with that, as half of something is worth a lot more than all of nothing.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities